Sponsor or institution
Clinical trials and research at Hellenic Cooperative Oncology Group
As of November 12, 2026, Find a Trial lists 6 clinical trials run by Hellenic Cooperative Oncology Group that are recruiting, at sites in 2 countries (most in Greece (6), Cyprus (1)). 3 were first registered in the last 30 days. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3New in 30 days
- 2Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| NSCLC biomarker study using tumor and blood samples to link genetics with prognosis and immunotherapy response | — | Limassol and 19 other locations | Recruiting | Oct 28, 2026 |
| ESR1 Mutations in Metastatic Hormone Receptor‑Positive Breast Cancer in Greece | — | Athens | Recruiting | Oct 27, 2026 |
| FRα expression in high-grade serous ovarian cancer (FRα positive) | — | Athens | Recruiting | Oct 22, 2026 |
| NalIriFOx as first-line therapy for metastatic pancreatic cancer | — | Athens and 8 other locations | Recruiting | Jul 23, 2026 |
| Why some new treatments work or stop working in advanced breast cancer | — | Athens and 4 other locations | Recruiting | Jul 15, 2025 |
| Assessing real-world outcomes of abemaciclib in breast cancer patients | — | Athens | Recruiting | Aug 2, 2021 |
All recruiting trials (6)
-
NSCLC biomarker study using tumor and blood samples to link genetics with prognosis and immunotherapy response
Researchers will test tumor tissue and blood from about 300 NSCLC patients to find genomic and immune markers that predict prognosis and response to immunotherapy.
-
ESR1 Mutations in Metastatic Hormone Receptor‑Positive Breast Cancer in Greece
This study tests how common ESR1 mutations are in Greek patients with advanced hormone receptor–positive, HER2‑negative breast cancer and looks at how those mutations relate to disease features and real-world treatment patterns.
-
FRα expression in high-grade serous ovarian cancer (FRα positive)
A retrospective study in Greece will test how often Folate Receptor Alpha is present in tumor samples from adults diagnosed with high-grade serous ovarian cancer.
-
NalIriFOx as first-line therapy for metastatic pancreatic cancer
This real-world study will see how NalIriFOx performs as a first-line treatment for metastatic pancreatic cancer in several Greek centers.
-
Why some new treatments work or stop working in advanced breast cancer
This project will see if biological markers explain why people with advanced breast cancer respond or become resistant to newer treatments like ADCs, immunotherapy, CDK inhibitors, and PARP inhibitors.
-
Assessing real-world outcomes of abemaciclib in breast cancer patients
This study is testing how well a drug called abemaciclib works for people with advanced breast cancer and what side effects they experience while using it alongside other treatments.
Quick answers
How many clinical trials run by Hellenic Cooperative Oncology Group are recruiting right now?
6, as of November 12, 2026. 3 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Greece (6 trials), Cyprus (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.